Focus compulsory courses
B2
10Cr
Code Details Bloc Organization Theory Practical Others Credits
PHAR0005-1 Introduction to specialized focus in conception and develoment of medicine - bioanalysis B2 Q1 10
Visites industrielles - [6h Visits of industrial plants]
- - [+]
Introduction à la biologie clinique - [6h Seminar]
- - [+]
Médicaments d'origine biosynthétique - [6h Seminar]
- - [+]
Stratégies de découverte des médicaments - [3h Seminar]
- - [+]
Chimie structurale des médicaments - [3h Seminar]
- - [+]
Management pharmaceutique - [3h Seminar]
- - [+]
Assurance de qualité - [3h Seminar]
- - [+]
Technologie pharmaceutique industrielle - [3h Seminar]
- - [+]
Analyses biopharmaceutiques - [6h Seminar]
- - [+]
Affaires règlementaires - [3h Seminar]
- - [+]
Etudes cliniques - [3h Seminar]
- - [+]
Méthodologie de rédaction - [3h Seminar]
- - [+]
Core curriculum courses
B1
60Cr
B2
30Cr
Code Details Bloc Organization Theory Practical Others Credits
PHAR0344-3 Medicines analysis
B1 Q1 45 28 - 7
PHAR0343-3 Pharmaceutical technologies and biopharmacy (part I)
B1 Q1 20 60 - 4
PHAC0341-2 Special pharmacology (Part I)
B1 Q1 25 - - 3
TOXI0341-2 Toxiocological chemistry, Part I B1 Q1 4
Toxiocological chemistry
25 - -
Toxicological chemistry, supplement for pharmacy - [12h Seminar]
- - [+]
BIOC0340-1 Clinical Chemistry (Part I) - [12h Seminar]
B1 Q1 22 - [+] 4
MBIO0002-1 Pharmaceutical Microbiology
B1 Q1 16 - - 2
PHAR2018-1 Officinal pharmaceutical good practices - [6h Seminar]
B1 Q1 10 - [+] 2
ECON0340-1 Pharmacoeconomy
B1 Q1 10 - - 1
PHAR0003-1
Pharmaceutical tehcnologies and biopharmacy (part II) - [5h Seminar]
Corequisite
Corequisite
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
B1 Q2 25 - [+] 4
PHAR0347-3 Practical work - Pharmaceutical technologies and Biopharmacy
Corequisite
Corequisite
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
B1 Q2 - 32 - 2
PHAC0342-2 Special pharmacology (Part II)
Corequisite
Corequisite
PHAC0341-2
Pharmacologie spéciale (Partim I)
B1 Q2 20 - - 2
TOXI0342-2 Clinical Toxicology and adverse drug events monitoring (Part II) - [12h Seminar]
Corequisite
Corequisite
TOXI0341-2
Chimie toxicologique, Partim I
B1 Q2 25 - [+] 4
BIOC0341-1 Clinical chemistry (2nd part) - [12h Seminar]
Corequisite
Corequisite
BIOC0340-1
Chimie clinique (Partim I)
B1 Q2 23 - [+] 4
PHAR0004-1 Pharamcotherapy and pharmaceutical cares - [10h Seminar]
B1 Q2 30 - [+] 5
SANT0005-1 Therapeutic approach - [30h Séminaire Interdisciplinaire]
B1 Q2 - - [+] 3
LEGI0340-2 Legislation and pharmaceutical ethics
B1 Q2 30 - - 4
PHAR2219-1 Integrated work 2 - [30h Learning based on problem-solv]
Corinne Charlier ,
Brigitte Evrard ,
Marianne Fillet ,
Pierre Francotte ,
Michel Frederich ,
Philippe Hubert ,
Anna Lechanteur ,
Allison Ledoux ,
Geneviève Philippe ,
Géraldine Piel ,
Anne-Catherine Servais ,
Vincent Seutin ,
Eric Ziemons
Corequisite
Corequisite
PHAC0341-2
Pharmacologie spéciale (Partim I)
PHAC0342-2
Pharmacologie spéciale (Partim II)
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
PHAR0344-3
Analyse des médicaments
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
B1 Q2 - - [+] 3
PHAR2020-1 Integrated practical activities B1 Q2 2
Integrated practical work
- 40 -
Industrial visits - [25h Visit]
Corequisite
Corequisite
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
PHAR0344-3
Analyse des médicaments
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
- - [+]
APPR0160-2 Professional development Seminar - [30h Learning based on problem-solv]
Laetitia Buret ,
Etienne Cavalier ,
Corinne Charlier ,
Alain Chaspierre ,
Raphaël Denooz ,
Brigitte Evrard ,
Marianne Fillet ,
Pierre Francotte ,
Michel Frederich ,
Philippe Hubert ,
Nathalie Jacobs ,
Anna Lechanteur ,
Frédéric Lecomte ,
Anne-Laure Lenoir ,
Geneviève Philippe ,
Géraldine Piel ,
Anne-Catherine Servais ,
Eric Ziemons
Corequisite
Corequisite
MTFE0351-3
Stage officinal et travail de fin d'études
B2 Q2 - - [+] 5
Compulsory Training
PHAR0721-1 Incorporation of pharmaceutical knowledge
Corinne Charlier ,
Raphaël Denooz ,
Brigitte Evrard ,
Marianne Fillet ,
Pierre Francotte ,
Michel Frederich ,
Julien Hanson ,
Patrick Herné ,
Frédéric Lecomte ,
Geneviève Philippe ,
Géraldine Piel ,
Bernard Pirotte ,
Anne-Catherine Servais ,
Vincent Seutin
Corequisite
Corequisite
MTFE0351-3
Stage officinal et travail de fin d'études
B2 Q2 - 50 - 5
MTFE0351-3 Officinal Internship and Thesis B2 Q2 20
Record of learning and participation to clinical research project - [100h Personal research]
- - [+]
Officinal internship and Thesis - [6mois internship]
Corequisite
Prerequisite
Prerequisite
TOXI0342-2
Chimie toxicologique y compris pharmacovigilance (Partim II)
PHAR2018-1
Bonnes pratiques pharmaceutiques officinales
PHAR0347-3
Travaux pratiques - Technologie pharmaceutique et biopharmacie
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
PHAC0342-2
Pharmacologie spéciale (Partim II)
PHAC0341-2
Pharmacologie spéciale (Partim I)
LEGI0340-2
Législation et déontologie pharmaceutiques
BIOC0341-1
Chimie clinique (Partim II)
Corequisite
PHAR0721-1
Intégration des connaissances pharmaceutiques
- - [+]
Notice : students must do a placement in a pharmacy of a legal duration of six months (26 weeks), and compile a learning record (dissertation) at the same time. This placement includes a compulsory introductory two-week internship, during the summer, after the bachelor's degree. For students who have acquired a minimum of 45 ECTS from block 1 of the master's degree, they can do their placement in a pharmacy during the summer holidays before starting block 2 of the master's degree (maximum 8 weeks). The remaining number of weeks (minimum 16 weeks) can be done within the framework of block 2 of the master's (2nd term).